Global Scans · Pharmaceuticals · Weekly Summary

• Ending Joe Biden's pharmaceutical shortages, returning the manufacture of essential drugs to the United States, and obtaining independence from China, by phasing in tariffs and import restrictions, which will create countless new American jobs. Wikimedia Foundation, Inc.
• Responding to The Pharmaceutical Journal's 2024 salary and job satisfaction survey, when asked if they had undertaken DPP training in the past year, just 83 out of 513 UK pharmacists across all sectors said yes, 390 said no and 40 (8%) said they planned to within 2025. The Pharmaceutical Journal
• Novo Nordisk, a leading global pharmaceutical company, announced it will invest $4.1 billion to build a second fill and finishing manufacturing site in Clayton, North Carolina, creating 1,000 new jobs in Johnston County. Economic Development Partnership of North Carolina
• The collaboration between the pharmaceutical industry and global tech companies, driven by technological innovation and investments in newer operation mechanisms, will create substantial job opportunities. Economic Times
• The investment in pharmaceutical innovation helps build on Scotland's strengths in health and life sciences, creating new jobs and opportunities as part of a fair and growing wellbeing economy. Scottish Development International
• Regeneron Pharmaceuticals is carrying out a $1.8 billion expansion of its Tarrytown, NY, headquarters campus that will bring eight new buildings totaling 900,000 square feet and 1,500+ new jobs upon completion in 2027. GEN - Genetic Engineering and Biotechnology News
• Recent research by the African Union - Made by Africa, Creating Value Through Integration - examines the vast potential of multicountry integrated value chains in sectors such as pharmaceuticals, apparel, and automobiles for economic diversification and job creation in Africa. Carnegie Endowment for International Peace
• Arrowhead Pharmaceuticals, a leading genetic medicine company, decided to expand their operations into Wisconsin by building a $220 million expansion in Verona that will create more than 230 high-paying jobs. Expansion Solutions
• Pharmaceutical giant Pfizer is set to invest more than US$ 2.5 billion to expand its manufacturing facilities in Europe, which would be good for creating more job opportunities. Transport Times
• In the pharmaceutical industry, 46% of respondents said they changed jobs in the last two years (the second highest percentage among all industries) and 24% said they are likely to change jobs within 2023. ACC Docket
• Swiss pharmaceutical giant Novartis said it plans to shed as many as 8,000 jobs globally, including 1,400 in Switzerland, as part of a previously disclosed restructuring plan aimed at saving some $1 billion in costs. WSJ
• The pharmaceutical lobby hit back with a constitutional challenge, two federal court challenges and a series of threats, including trade disputes, job losses and a warning that they would delay the launch of new drugs in Canada. CBC
• Industry leaders have warned against imposing sanctions on Russian natural gas, saying it could lead to substantial job losses in the chemical, mining and pharmaceutical sectors. The New York Times
• US pharmaceutical company Eli Lilly will create a total of 800 new jobs in Ireland following the proposal of a €400 million investment. JOE.ie
• Eli Lilly and Company, the US pharmaceutical giant, plans to invest more than €400m in a new manufacturing facility in Limerick that will create more than 300 full-time jobs. Silicon Republic
• The African pharmaceutical sector is expected to grow from $19 billion in 2012 to $66 billion by 2022-the fastest growing in the world; the health and wellness sector is projected to be worth around $259 billion by 2030, with the potential to create over 16 million jobs. Brookings Institute
• Sectors forecast to see the highest jobs growth for graduates in 2022 are the built environment (48% growth), energy, engineering and industry (41% growth), and health and pharmaceuticals (37% growth). Personnel Today
• The most optimistic vision for the AMA it is that it will incentive more robust pharmaceutical supply chains in Africa, thereby creating jobs and opportunity for innovation closer to home. Council on Foreign Relations
• If Boris Johnson and Rishi Sunak really want to move from jabs, jabs, jabs to jobs, jobs, jobs, they will waive intellectual property on Covid-19 vaccines and force pharmaceutical companies to share their vaccine technology with the world. Left Foot Forward: Leading the UK's progressive debate
• Pharmaceutical company AstraZeneca will create 100 jobs in Ireland as it invests $360 million in an advanced manufacturing facility in Dublin. The Irish Times
• About 150 jobs are set to disappear from Manukau as Australian Pharmaceutical Industries plans to stop manufacturing in New Zealand. NZ Herald

Last updated: 25 November 2024